P516 Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trialsJulián Panés, Chunyan Su, J F Colombel et al.|Journal of Crohn s and Colitis|2018Cited by 7